by Dr Simone | Jun 30, 2020 | Charles B SimoneMD, CORONAVIRUS, Dr Simone, Remdesivir
The U.S. taxpayer played the major role in funding the discovery of remdesivir and its use in treating coronaviruses.
Now the U.S. taxpayer is being told to pay $3,120 for five doses of remdesivir to decrease recovery time by a mere four days for hospitalized COVID-19 patients.
by Dr Simone | Mar 26, 2020 | ACE2, Big Pharma, Bioweapon, Charles B SimoneMD, CORONAVIRUS, COVID-19, Infections, Inflammation, Myocarditis
I asked myself several questions.
WHY is the current CoVID-19 coronavirus (SARS-Cov-2) so powerful, and so virulent?
WHY does it preferentially seek out people who have high ACE2 docking sites on their cells due to their prescription medicines or diseases, obesity, smoking?
WHY does it cause tremendous immune system dysfunction in many infected people, similar to what we see with AIDS patients?
And Who funded this?
by Dr Simone | Mar 21, 2020 | Charles B SimoneMD, CORONAVIRUS
DRUGS INCREASE ACE2 THAT IS NEEDED BY SARS-CoV-2 (COVID-19 Coronavirus) TO ATTACH AND INFECT CELLS of the lung, intestine, kidney, blood vessel.
The more ACE2, the more infection. This may be the reason why the elderly who are treated with these drugs, have a greater risk of death / severe side effects
by Dr Simone | Jan 22, 2020 | Flu, Sinus Hygiene
Dr Charles B Simone M.MS., M.D. discusses Coronavirus with hosts Bob Sellers and Alison Maloni on the new Newsmax TV program “National Report” Jan, 22 2020.
by lavenduski | Jul 19, 2015 | ACE2, Big Pharma, Bioweapon, Charles B SimoneMD, CORONAVIRUS, COVID-19, Infections, Inflammation, Myocarditis
I asked myself several questions.
WHY is the current CoVID-19 coronavirus (SARS-Cov-2) so powerful, and so virulent?
WHY does it preferentially seek out people who have high ACE2 docking sites on their cells due to their prescription medicines or diseases, obesity, smoking?
WHY does it cause tremendous immune system dysfunction in many infected people, similar to what we see with AIDS patients?
And Who funded this?